Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.
With the development of medical technology level, more and more companies participate in this industry.
According to this study, over the next five years the Wound Care Biologics market will register a 10.5% CAGR in terms of revenue, the global market size will reach US$ 4690 million by 2024, from US$ 2580 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Wound Care Biologics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Wound Care Biologics market by product type, application, key manufacturers and key regions and countries.
This study considers the Wound Care Biologics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Biologic Skin Substitutes
Enzyme Based Formulations
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Smith & Nephew
Derma Sciences, Inc
Amnio Technology, LLC
Pinnacle Transplant Technologies
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Wound Care Biologics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Wound Care Biologics market by identifying its various subsegments.
Focuses on the key global Wound Care Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Wound Care Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Wound Care Biologics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.